Try our Advanced Search for more refined results
- Law360
- Law360 UK
- Law360 Pulse
- Law360 Employment Authority
- Law360 Tax Authority
- Law360 Insurance Authority
- Law360 Real Estate Authority
- Law360 Healthcare Authority
- Law360 Bankruptcy Authority
- Products
- Lexis®
- Law360 In-Depth
- Law360 Podcasts
- Rankings
- Regional Powerhouses
- Law360's MVPs
- Women in Law Report
- Law360 400
- Diversity Snapshot
- Practice Groups of the Year
- Rising Stars
- Titans of the Plaintiffs Bar
- Sections
- Adv. Search & Platform Tools
- About all sections
- Browse all sections
- Banking
- Bankruptcy
- Class Action
- Competition
- Employment
- Energy
- Expert Analysis
- Insurance
- Intellectual Property
- Product Liability
- Securities
- Beta Tools
- Track docs
- Track attorneys
- Track judges
United States of America, et al. v. Takeda Pharmaceuticals America, Inc. , et al.
Case Number:
1:14-cv-09412
Court:
Nature of Suit:
375(Other Statutes: False Claims Act)
Judge:
Honorable Harry D. Leinenweber
Firms
- Arnold & Porter
- Behn & Wyetzner
- Berger Montague
- Covington & Burling
- Crowell & Moring
- Donohue Brown Mathewson & Smyth LLC
- Faegre Drinker
- Faruqi & Faruqi
- Kirkland & Ellis
- Sidley Austin
- Troutman Pepper
- Walden Macht
Companies
- Allergan PLC
- Astellas Pharma Inc.
- Boehringer Ingelheim
- Boehringer Ingelheim Vetmedica Inc.
- Celgene Corp.
- Daiichi Sankyo Co.
- Eli Lilly & Co.
- Organon & Co.
- Santarus, Inc.
- Takeda Pharmaceutical Co. Ltd.
- Teva Pharmaceutical Industries Ltd.
Sectors & Industries:
-
May 09, 2023
Eli Lilly Drug Rebate Damages Tripled To $183M
An Illinois federal judge on Tuesday tripled the $61 million in damages imposed on Eli Lilly & Co. in a False Claims Act case targeting more than a decade of drug rebate miscalculations by the pharmaceutical company, bringing the total to more than $183 million.
-
April 27, 2023
Eli Lilly Unable To Sink $61M Award In Drug Rebate Case
An Illinois federal judge has proposed clipping $147,000 from a jury's $61 million award in a false claims case targeting more than a decade of drug rebate miscalculations by Eli Lilly & Co., but otherwise refused to unwind the award.
-
September 01, 2022
Eli Lilly Wants New Trial Over Medicaid Rebate Calculations
Eli Lilly and Co. has asked an Illinois federal judge to unwind a jury's $61 million verdict in a whistleblower's suit claiming the drug company intentionally shorted Medicaid on drug rebates, arguing the whistleblower can't prove the company knowingly violated the law.
-
August 03, 2022
Eli Lilly Must Pay $61M For False Medicaid Rebate Calculation
An Illinois federal jury hit Eli Lilly and Co. with a $61 million verdict Wednesday after finding that the drug manufacturer deliberately shorted the Medicaid program by leaving retroactive drug price increases out of the metrics it was required to include for drug rebate calculations.
-
August 02, 2022
Eli Lilly 'Proud' Of Drug Rebate Specialist's Process
Eli Lilly and Co. tapped the right person to calculate drug rebate payments for Medicaid under vague rules and regulations, and the company didn't defraud the government of $60 million simply because her metrics were wrong, an Illinois federal jury heard Tuesday.
-
July 22, 2022
Eli Lilly Pocketed $60M Meant For Medicaid, Ill. Jury Hears
Eli Lilly and Co. defrauded the federal government of $60 million by deliberately leaving retroactive drug price increases out of the metrics it was required to include for Medicaid rebate calculations, an Illinois federal jury heard Friday.
-
November 07, 2018
Medicaid Rebate Suit Not Barred By Similar Suits: Ex-Exec
A former pharmaceutical executive accusing Astellas Pharma US and Eli Lilly and Co. of shorting the federal government on drug rebate payments asked an Illinois federal court not to dismiss the suit based on the fact that he's accused other companies of similar wrongdoing before.